US 9926380
Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
granted A61KA61K39/00A61K45/06
Quick answer
US patent 9926380 (Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease) held by The Board of Regents of the University of Texas System expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K39/00, A61K45/06, A61K47/6851, A61K47/6871